ANACOR PHARMACEUTICALS INC's ticker is ANAC and the CUSIP is 032420101. A total of 102 filers reported holding ANACOR PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.92 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $2,143,000 | -87.4% | 40,100 | -73.4% | 0.01% | -86.1% |
| Q4 2015 | $17,006,000 | -87.8% | 150,537 | -87.3% | 0.04% | -86.7% |
| Q3 2015 | $139,558,000 | +144.6% | 1,185,607 | +60.9% | 0.27% | +150.0% |
| Q2 2015 | $57,063,000 | -6.0% | 736,962 | -29.8% | 0.11% | -4.4% |
| Q1 2015 | $60,730,000 | +97.5% | 1,049,789 | +10.1% | 0.11% | +73.8% |
| Q4 2014 | $30,747,000 | +139.3% | 953,382 | +81.6% | 0.06% | +97.0% |
| Q3 2014 | $12,850,000 | +86.6% | 525,124 | +35.2% | 0.03% | +73.7% |
| Q2 2014 | $6,888,000 | -19.5% | 388,513 | -9.1% | 0.02% | -24.0% |
| Q1 2014 | $8,554,000 | +51.9% | 427,497 | +27.4% | 0.02% | +38.9% |
| Q4 2013 | $5,631,000 | +1546.5% | 335,554 | +448.1% | 0.02% | +1700.0% |
| Q2 2013 | $342,000 | – | 61,217 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 1,067,892 | $61,778,000 | 25.76% |
| VHCP Management, LLC | 1,178,474 | $68,175,000 | 15.70% |
| Palo Alto Investors LP | 3,259,045 | $188,536,000 | 9.32% |
| HWG Holdings LP | 69,898 | $4,044,000 | 6.53% |
| Consonance Capital Management LP | 830,151 | $48,024,000 | 4.37% |
| EMORY UNIVERSITY | 23,325 | $1,349,000 | 2.55% |
| Baker Brothers Advisors | 4,204,702 | $243,242,000 | 2.02% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 117,875 | $6,819,000 | 1.55% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 595,300 | $34,438,000 | 1.46% |
| Century Capital Management, LLC | 1,030,483 | $45,609,000 | 1.31% |